We are Sorry, This Page doesn't Exist
Inovio Shares Rise On Positive Data For Coronavirus Vaccine Candidate That"s Stable At Room Temps
Inovio Pharmaceuticals Inc (NASDAQ: INO) shares were trading higher Thursday after the company released positive Phase 1 data on to its COVID-19 DNA vaccine candidate. read more.....»»
Pfizer and Moderna vaccines should be safe for most Americans, but 5 groups may want to wait for more data before getting shots
An FDA review found there was "insufficient data" to determine whether Pfizer's coronavirus vaccine is safe for pregnant people and kids under 16. Margaret Keenan was the first person to be given the Pfizer coronavirus vaccine outsid.....»»
Moderna just sped up the timeline for testing its promising coronavirus vaccine. We got the inside story on how the biotech upstart developed the injection in record time.
Moderna The biotech Moderna developed a potential coronavirus vaccine in re.....»»
Twitter gains users, beats estimates but ad trends alarm investors
Twitter Inc on Thursday reported higher first-quarter revenue and a smaller loss than analysts had expected amid the coronavirus pandemic, but its shares fell as investors fretted about potential weakness in the second quarter......»»
US stock futures rise after solid tech earnings, Facebook up more than 10%
Stocks ended higher Wednesday on the back of positive data from a potential coronavirus treatment from Gilead Sciences, while traders assessed a sharp drop in U.S. economic activity......»»
US stock futures rise after solid tech earnings
Stocks ended higher Wednesday on the back of positive data from a potential coronavirus treatment from Gilead Sciences, while traders assessed a sharp drop in U.S. economic activity......»»
Stocks close higher on hopes for a virus treatment
Stocks ended higher Wednesday on the back of positive data from a potential coronavirus treatment from Gilead Sciences, while traders assessed a sharp drop in U.S. economic activity......»»
Stocks close higher on hopes for a virus treatment
Stocks ended higher Wednesday on the back of positive data from a potential coronavirus treatment from Gilead Sciences, while traders assessed a sharp drop in U.S. economic activity......»»
Inovio Analysts Project About 24% Upside Potential Amid Optimism On Coronavirus DNA Vaccine
Coronavirus vaccine play Inovio Pharmaceuticals Inc (NASDAQ: INO) announced the completion of enrollment in the Phase 1 trial of its COVID-19 DNA vaccine INO-4800 .....»»
Stocks surge on hopes for a coronavirus treatment
Stocks rose Wednesday on the back of positive data from a potential coronavirus treatment from Gilead Sciences as traders also assessed a sharp drop in U.S. economic activity......»»
Stocks surge on hopes for a coronavirus treatment
Stocks rose Wednesday on the back of positive data from a potential coronavirus treatment from Gilead Sciences as traders also assessed a sharp drop in U.S. economic activity......»»
Moderna News: MRNA Stock Surges on Potential Coronavirus Vaccine
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Moderna news rega.....»»
The coronavirus could affect the accuracy of the 2020 census — and that could decide who gets a vaccine
The 2020 census is underway, but experts fear the coronavirus pandemic could prevent an accurate count of the US population. The government uses census data to allocate resources, such as a potential coronavirus vaccine. .....»»
Hospitality industry analysts compare current COVID-19 era to 9/11, Great Recession
As the coronavirus began to spread into Wisconsin, the data collection agency STR Inc. reported that revenue per available hotel room in Milwaukee declined 8.7% in the week ending March 7. Jan Fajtak, senior vice president of lodging insights for STR, s.....»»
Working on a coronavirus vaccine? This clothing retailer wants to sell you a name for it.
A Massachusetts-based business has applied for three trademarks for a coronavirus vaccine in recent weeks. But it’s not Moderna Inc. (Nasdaq: MRNA), which is about to start clinical testing of a potential vaccine for the global outbreak. Nor is it Cur.....»»
The inside story of how the $10 billion biotech Moderna developed a potential coronavirus vaccine in record time
Moderna The $10 billion biotech.....»»
A small group of scientists, execs, and VCs are $277 million richer as their companies race to create a coronavirus vaccine. Here are 7 who have raked in huge sums.
Moderna Gilead, Moderna, and Novavax have all enjoyed massive gains after announcing potential coronavirus drugs, leading th.....»»
Buzzy biotech Moderna is "looking at all options" to ramp up production just days after shipping the first potential coronavirus vaccine (MRNA)
Reuters A startup biotech is leading .....»»
Hot biotech Moderna spikes 22% as it ships the first potential coronavirus vaccine for human testing (MRNA)
Associated Press Biotech company Moderna jum.....»»
Global stocks climb on China tariffs cuts, US jobs data, and Wuhan coronavirus vaccine hopes
Reuters / Brendan McDermid Stocks jumped on Thursday thanks to a raft of positive news. Chinese officials will halve duties on $75 billion worth of US goods starting on Valen.....»»